Elevance Health Executive Compensation Details Revealed
Ticker: ELV · Form: DEF 14A · Filed: Mar 28, 2025 · CIK: 1156039
Sentiment: neutral
Topics: proxy-statement, executive-compensation, equity-awards
TL;DR
Elevance Health dropped its proxy statement detailing exec pay for 2024. Shareholders get the scoop on stock awards.
AI Summary
Elevance Health, Inc. filed its DEF 14A on March 28, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on equity awards granted to its principal executive officer (PEO) and non-PEO named executive officers, with details on the value of outstanding and unvested awards as of the end of the fiscal year.
Why It Matters
This filing provides shareholders with crucial information regarding how executive compensation is structured and awarded, impacting corporate governance and investor confidence.
Risk Assessment
Risk Level: low — This is a routine annual filing providing information on executive compensation and is not indicative of immediate financial risk.
Key Numbers
- 2024 — Fiscal Year (Compensation details are for this year.)
- 2023 — Prior Fiscal Year (Comparative data may be included.)
Key Players & Entities
- Elevance Health, Inc. (company) — Filer of the DEF 14A
- 2024-12-31 (date) — Fiscal year end for compensation details
- 20250328 (date) — Filing date of the DEF 14A
- 20250514 (date) — Conformed period of report
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Proxy Statement, is used to solicit shareholder votes on important corporate matters, including the election of directors and executive compensation.
Who are the named executive officers for whom compensation details are provided?
The filing provides details for the Principal Executive Officer (PEO) and Non-PEO Named Executive Officers, with specific individuals like Boudreaux, Kaye, Haytaian, Norwood, and Kendrick mentioned in relation to award dates.
What types of equity awards are discussed in the filing?
The filing discusses equity awards granted in covered years that are outstanding and unvested at the end of the fiscal year, specifically for PEO and Non-PEO members.
When was Elevance Health, Inc. previously known as Anthem, Inc.?
Elevance Health, Inc. was formerly known as Anthem, Inc. with a date of name change on December 2, 2014.
What is the business address and phone number for Elevance Health, Inc.?
The business address is 220 Virginia Avenue, Indianapolis, IN 46204, and the business phone number is 800-331-1476.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 28, 2025 regarding Elevance Health, Inc. (ELV).